DrugPatentWatch Database Preview
Drugs in Development Information for Anlotinib
Summary for Anlotinib
| US Patents | 2 |
| International Patents | 29 |
| US Patent Applications | 6 |
| WIPO Patent Applications | 10 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 2 (2017-02-01) |
| Vendors | 13 |
US Patents for Anlotinib
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Anlotinib | ➤ Try a Free Trial | Spiro substituted compounds as angiogenesis inhibitors | ➤ Try a Free Trial | |
| Anlotinib | ➤ Try a Free Trial | Process for preparing an anti-cancer agent, 1-((4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-6-methoxyquinolin-7-yloxy)meth- yl)cyclopropanamine, its crystalline form and its salts | Advenchen Pharmaceuticals, LLC (Moorpark, CA) | ➤ Try a Free Trial |
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
International Patents for Anlotinib
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Anlotinib | Australia | 2008226666 | 2027-03-14 | ➤ Try a Free Trial |
| Anlotinib | Brazil | PI0805826 | 2027-03-14 | ➤ Try a Free Trial |
| Anlotinib | Canada | 2709220 | 2027-03-14 | ➤ Try a Free Trial |
| Anlotinib | China | 101809012 | 2027-03-14 | ➤ Try a Free Trial |
| Anlotinib | China | 103467454 | 2027-03-14 | ➤ Try a Free Trial |
| Anlotinib | China | 103483319 | 2027-03-14 | ➤ Try a Free Trial |
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
